4.7 Article

RhoA determines disease progression by controlling neutrophil motility and restricting hyperresponsiveness

期刊

BLOOD
卷 123, 期 23, 页码 3635-3645

出版社

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2014-02-557843

关键词

-

资金

  1. Health Research Board and Science Foundation Ireland
  2. INSERM, Centre National de la Recherche Scientifique, and Inflamex
  3. Danish Research Foundation
  4. Science Foundation Ireland Stokes award

向作者/读者索取更多资源

Neutrophil responses are central to host protection and inflammation. Neutrophil activation follows a 2-step process in which priming amplifies responses to activating stimuli. Priming is essential for life span extension, chemotaxis, and respiratory burst activity. Here we show that the cytoskeletal organizer RhoA suppresses neutrophil priming via formins. Premature granule exocytosis in Rho-deficient neutrophils activated numerous signaling pathways and amplified superoxide generation. Deletion of Rho altered front-to-back coordination by simultaneously increasing uropod elongation, leading edge formation, and random migration. Concomitant negative and positive regulation of beta(2) integrin-independent and beta(2) integrin-dependent migration, respectively, reveal Rho as a key decision point in the neutrophil response to discrete chemotactic agents. Although even restricted influx of Rho-deficient hyperactive neutrophils exacerbated lipopolysaccharide-mediated lung injury, deleting Rho in innate immune cells was highly protective in influenza A virus infection. Hence, Rho is a key regulator of disease progression by maintaining neutrophil quiescence and suppressing hyperresponsiveness.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据